EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access · CC BY-NC 4.0

Analysis of Virologic and Clinical Predictors for Hospitalization, Supported by Machine Learning, in a Phase 3 Molnupiravir COVID ‐19 Treatment Trial

Matthew G Johnson iD, Jessica M Conway, Laura E Liao iD, David W Hilbert, Erin Jensen, Dorothy McCoy iD, Yanfen Guan, Ying Zhang, Michelle L Brown iD, Dana D Byrne, Carisa De Anda iD

Clinical and Translational Science · 2026

DOI: 10.1111/cts.70720 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Translational Science, 2026. Verfasst von Matthew G Johnson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, New Jersey, USA. Hauptthemen laut MEDLINE: Hospitalization, COVID-19, Machine Learning, SARS-CoV-2. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Machine learning (ML) is increasingly being used in clinical medicine. The objective of this study was to identify factors predictive of hospitalization, with the support of ML, in outpatients with mild‐to‐moderate COVID‐19. Unvaccinated adults with mild‐to‐moderate COVID‐19 were randomized 1:1 to molnupiravir or placebo in MOVe‐OUT (NCT04575597). In this post hoc analysis, various factors were evaluated among participants who progressed or did not progress to hospitalization. ML was used as an unbiased method to evaluate multiple factors for their association with hospitalization in placebo‐treated participants. Participants who progressed to hospitalization (HP) were more likely versus those who remained nonhospitalized (nonHP) to be male; age ≥ 65 years old; have active cancer, diabetes mellitus, moderate COVID‐19, and negative nucleocapsid and neutralizing antibody status at baseline (study intervention Day 1). In HP, baseline mean viral load (VL) was 7.51 vs. 6.83 log 10 copies/mL among participants who remained nonHP. Baseline mean CRP was 49.93 in HP vs. 16.77 mg/L in nonHP; postbaseline values increased in HP vs. nonHP. Baseline mean ALC was 1.07 vs. 1.54 × 10 9 /L, respectively; postbaseline values decreased on Days 3 and 5 in HP. ML analysis identified baseline VL, CRP, ALC, calcium, and mean change in CRP, ALC, and LDH as predictors of hospitalization. The ML model supported the initial findings that a higher VL at baseline with an increasing CRP and decreasing ALC may help identify COVID‐19 patients at high risk for hospitalization. ML could be utilized to identify biomarkers predictive of hospitalization in future pandemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HospitalizationCOVID-19Machine LearningSARS-CoV-2COVID-19 Drug TreatmentAntiviral AgentsHumansMaleAgedFemalePredictive Learning ModelsViral LoadMiddle AgedPrediction Algorithms

Stichwörter der Autor:innen

COVID‐19biomarkershospitalizationmachine learningpredictors

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, New Jersey, USA.
  • Department of Mathematics and Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, USA.

ORCID-Profile: Matthew G Johnson, Laura E Liao, Dorothy McCoy, Michelle L Brown, Carisa De Anda

Zitieren

APA

Johnson, M. G., Conway, J. M., Liao, L. E., Hilbert, D. W., Jensen, E., McCoy, D., Guan, Y., Zhang, Y., Brown, M. L., Byrne, D. D., & De Anda, C. (2026). Analysis of Virologic and Clinical Predictors for Hospitalization, Supported by Machine Learning, in a Phase 3 Molnupiravir COVID ‐19 Treatment Trial. Clinical and Translational Science. https://doi.org/10.1111/cts.70720

Vancouver

Johnson MG, Conway JM, Liao LE, Hilbert DW, Jensen E, McCoy D, et al. Analysis of Virologic and Clinical Predictors for Hospitalization, Supported by Machine Learning, in a Phase 3 Molnupiravir COVID ‐19 Treatment Trial. Clinical and Translational Science. 2026. doi:10.1111/cts.70720

BibTeX
@article{Johnson2026,
  author = {Johnson, Matthew G and Conway, Jessica M and Liao, Laura E and Hilbert, David W and Jensen, Erin and McCoy, Dorothy and Guan, Yanfen and Zhang, Ying and Brown, Michelle L and Byrne, Dana D and De Anda, Carisa},
  title = {Analysis of Virologic and Clinical Predictors for Hospitalization, Supported by Machine Learning, in a Phase 3 Molnupiravir COVID ‐19 Treatment Trial},
  journal = {Clinical and Translational Science},
  year = {2026},
  doi = {10.1111/cts.70720}
}
Kostenlos starten →